SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-039719
Filing Date
2022-03-30
Accepted
2022-03-30 08:01:45
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm223491d3_defa14a.htm DEFA14A 12760
2 GRAPHIC tm223491d3_defa14aimg001.jpg GRAPHIC 192820
3 GRAPHIC tm223491d3_defa14aimg002.jpg GRAPHIC 113095
  Complete submission text file 0001104659-22-039719.txt   435337
Mailing Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET, SUITE 300 CAMBRIDGE MA 02139 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38586 | Film No.: 22783222
SIC: 2836 Biological Products, (No Diagnostic Substances)